Arteriosclerosis, Vol 9, 279-288, Copyright © 1989 by American Heart Association

ARTICLES

Regulation of major histocompatibility gene expression in human vascular smooth muscle cells

SJ Warner, GB Friedman and P Libby
Department of Medicine (Cardiology), Tufts University, Boston, MA 02111.

Human atheromata, but not normal blood vessels, contain numerous smooth muscle cells (SMC) that bear class II major histocompatibility (MHC) antigens. These lesions also contain leukocytes that can secrete cytokines, which may modulate SMC functions. Because of morphologic evidence for immune-activated (class II+) SMC in vascular lesions, we studied the regulation by cytokines of MHC gene expression in SMC cultured from human vessels. Under basal conditions, these SMC contained mRNA for class I MHC (detected by Northern blotting with a cDNA probe for HLA-B7) and expressed surface class I MHC product determined by enzyme-linked immunoassay with monoclonal antibody (MAb) W6/32. Unstimulated SMC contained little or no class II MHC mRNA (probed with HLA-DR alpha cDNA) or surface antigen (examined using MAb I2). Secretory products of activated human leukocytes (the cell-free supernatant of a mixed leukocyte reaction) induced class II MHC antigen expression by SMC after 3 days. Treatment of SMC with interferon (IFN)- alpha or -beta (1000 U/ml for 72 hours) increased class I MHC mRNA content and surface antigen but did not alter class II expression. Immune IFN (IFN-gamma), a leukocyte product known to induce class II MHC expression in classical antigen presenting cells as well as epithelial and endothelial cells, not only increased class I MHC expression by SMC but also induced substantial levels of class II MHC mRNA and surface antigen. IFN-gamma (ED50 approximately 10 U/ml) increased class II MHC mRNA maximally after 2 to 3 days and surface expression linearly from 1 to 4 days. Immunohistochemical study demonstrated few class II+ SMC in cultured human SMC under basal conditions but homogeneous expression of high levels of DR antigen after exposure to IFN-gamma for 3 days. Neither interleukin-1 (IL-1 alpha or beta), tumor necrosis factor alpha (TNF), nor endotoxin altered class II expression by SMC. Local secretion of IFN-gamma by activated leukocytes may account for the presence of HLA-DR+ SMC in the human atheroma. Immune activation of SMC might participate in the pathogenesis of vasculitis and arteriosclerosis, particularly in the form found in the coronary arteries of transplanted hearts.

This article has been cited by other articles:

				S. Schulte, G. K. Sukhova, and P. Libby Genetically Programmed Biases in Th1 and Th2 Immune Responses Modulate Atherogenesis Am. J. Pathol., June 1, 2008; 172(6): 1500 - 1508. [Abstract] [Full Text] [PDF]

				H. Veler, A. Hu, S. Fatma, J. S. Grunstein, C. M. DeStephan, D. Campbell, J. S. Orange, and M. M. Grunstein Superantigen Presentation by Airway Smooth Muscle to CD4+ T Lymphocytes Elicits Reciprocal Proasthmatic Changes in Airway Function J. Immunol., March 15, 2007; 178(6): 3627 - 3636. [Abstract] [Full Text] [PDF]

				F. Meisner, D. Walcher, F. Gizard, X. Kapfer, R. Huber, A. Noak, L. Sunder-Plassmann, H. Bach, C. Haug, M. Bachem, et al. Effect of Rosiglitazone Treatment on Plaque Inflammation and Collagen Content in Nondiabetic Patients: Data From a Randomized Placebo-Controlled Trial Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 845 - 850. [Abstract] [Full Text] [PDF]

				G. Buttice, J. Miller, L. Wang, and B. D. Smith Interferon-{gamma} Induces Major Histocompatibility Class II Transactivator (CIITA), Which Mediates Collagen Repression and Major Histocompatibility Class II Activation by Human Aortic Smooth Muscle Cells Circ. Res., March 3, 2006; 98(4): 472 - 479. [Abstract] [Full Text] [PDF]

				K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques Am. J. Pathol., March 1, 2001; 158(3): 1039 - 1051. [Abstract] [Full Text] [PDF]

				J.L Mehta and D.Y Li Inflammation in ischemic heart disease: Response to tissue injury or a pathogenetic villain? Cardiovasc Res, August 1, 1999; 43(2): 291 - 299. [Full Text] [PDF]

				T. Matsumura, K. Kugiyama, S. Sugiyama, Y. Ota, H. Doi, N. Ogata, H. Oka, and H. Yasue Suppression of Atherosclerotic Development in Watanabe Heritable Hyperlipidemic Rabbits Treated With an Oral Antiallergic Drug, Tranilast Circulation, February 23, 1999; 99(7): 919 - 924. [Abstract] [Full Text] [PDF]

				M. A. Carluccio, M. Massaro, C. Bonfrate, L. Siculella, M. Maffia, G. Nicolardi, A. Distante, C. Storelli, and Raffaele De Caterina Oleic Acid Inhibits Endothelial Activation : A Direct Vascular Antiatherogenic Mechanism of a Nutritional Component in the Mediterranean Diet Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 220 - 228. [Abstract] [Full Text] [PDF]

				R. Rabbani and E. J. Topol Strategies to achieve coronary arterial plaque stabilization Cardiovasc Res, February 1, 1999; 41(2): 402 - 417. [Abstract] [Full Text] [PDF]

				R. De Caterina, W. Bernini, M. A. Carluccio, J. K. Liao, and P. Libby Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids J. Lipid Res., May 1, 1998; 39(5): 1062 - 1070. [Abstract] [Full Text]

				W. S. Shin, Y.-H. Hong, H.-B. Peng, R. De Caterina, P. Libby, and J. K. Liao Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-[IMAGE] J. Biol. Chem., May 10, 1996; 271(19): 11317 - 11324. [Abstract] [Full Text] [PDF]

				Y.-J. Geng, Q. Wu, M. Muszynski, G. K. Hansson, and P. Libby Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-{gamma}, Tumor Necrosis Factor–{alpha}, and Interleukin-1ß Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 19 - 27. [Abstract] [Full Text]

				S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text]

				P. Libby Molecular Bases of the Acute Coronary Syndromes Circulation, June 1, 1995; 91(11): 2844 - 2850. [Full Text]

				G. Basta, G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, C. Fu, T. Kislinger, D. M. Stern, A. M. Schmidt, and R. De Caterina Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses Circulation, February 19, 2002; 105(7): 816 - 822. [Abstract] [Full Text] [PDF]